The Healthea Group
The Healthea Group is a European CDMO, formed in 2025 by Riverside-backed BioDue, that provides full-service development, manufacturing, regulatory, and licensing of medical devices, food supplements, cosmetics, and specialty foods across seven production facilities in Italy and Sweden.
- Company typePrivate
- Founded2025
- HeadquartersBarberino Tavarnelle, Italy
- Headcount1–10
- GTM typeB2B
- OfferingServices
What The Healthea Group does
The Healthea Group is a European contract development and manufacturing organization (CDMO) formed in 2025 by Riverside-backed Italian CDMO BioDue (originally founded 1986) and its operating peers Farcoderma, Healthea Licensing, Biokosmes, and Rolf Kullgren. The group provides full-service development, formulation, production, packaging, regulatory affairs, and commercialization support to pharmaceutical, nutraceutical, cosmetic, and medical-device customers across all major pharmaceutical forms (tablets, capsules, powders, oral liquids, solids, semi-solids, topical liquids). It operates seven production facilities spanning more than 40,000 m² across Italy and Sweden, employs 248+ specialized professionals, and runs three R&D laboratories plus an accredited microbiological laboratory.
Differentiated technology assets include proprietary Caps in Caps and Multilayer Tablets formulation architectures (both patent pending) that address incompatible-ingredient combinations and controlled-release kinetics, respectively. The group also maintains a Ready-to-Market portfolio of 60+ medical devices and formulations across 14 therapeutic areas, with patent-pending products supported by clinical studies.
Revenue is generated through three streams: contract manufacturing services (one-off project fees), licensing and royalties on Ready-to-Market products, and professional-services fees for R&D and regulatory support. Pricing is quote-based and not publicly disclosed. Customers are European enterprise pharma/nutraceutical buyers, mid-market niche health-product companies, and consumer health brands seeking white-label/turnkey launches. Distribution is exclusively B2B direct sales. The group is privately held by The Riverside Company; leadership comprises Group CEO Davide Masini, COO Francesco Boldi, CTO Giorgio Terzino, CCO Andrea Maggioni, and CDO Giulia Nannoni.
The Healthea Group firmographics
Firmographics- Name
- The Healthea Group
- Legal name
- The Healthea Group
- Website
- https://healtheagroup.eu
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- The Healthea Group is a European CDMO, formed in 2025 by Riverside-backed BioDue, that provides full-service development, manufacturing, regulatory, and licensing of medical devices, food supplements, cosmetics, and specialty foods across seven production facilities in Italy and Sweden.
- Ownership category
- akta.pro rank
The Healthea Group industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing (CDMO)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
Keywords
Where The Healthea Group is headquartered
LocationHeadquarters
- HQ city
- Barberino Tavarnelle
- HQ country
- Italy
- HQ region
- Europe
Offices7 records
Markets served
The Healthea Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Full-service CDMO providing contract manufacturing of health products including food supplements, medical devices, cosmetics, and foods for special medical purposes. Services span from raw material sourcing, development and formulation, production, packaging, regulatory affairs to commercialization.
- Ready-to-Market Products: Licensing and sale of pre-developed, industrialized products covering 14 therapeutic areas including medical devices, food supplements, and cosmetics with complete dossiers and registrations.
- R&D and Regulatory Services: Research and development support including formulation development, optimization of existing formulations, regulatory consulting, and certification support for market access.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
The Healthea Group product offering
Product offeringCore offering
The Healthea Group is a European CDMO providing contract development and manufacturing services for medical devices, cosmetics, food supplements, and foods for special medical purposes. It offers a full-service production model covering R&D, formulation, manufacturing, packaging, regulatory affairs, and logistics, supported by 7 facilities across Italy and Sweden and a portfolio of over 60 ready-to-market medical device references.
Product overview
The Healthea Group is a European CDMO (Contract Development and Manufacturing Organization) offering comprehensive pharmaceutical/healthcare manufacturing services through its subsidiary companies: Biodue (food supplements, medical devices, cosmetics), FARCODERMA (production facility with accredited microbiological lab), Healthea Licensing (ready-to-market products licensing), Biokosmes (cosmetics and medical devices), and Rolf Kullgren (medical devices and cosmetics). The group provides Full Service Production covering R&D, formulation, manufacturing, packaging, and logistics, along with Regulatory Affairs support and Ready to Market Solutions with over 60 medical devices across 14 therapeutic areas. Key innovative technologies include Caps in Caps (for incompatible active combinations) and Multilayer Tablets (for controlled release). With 7 production facilities spanning over 40,000 m², the group manufactures all pharmaceutical forms including tablets, capsules, powders, oral liquids, solids, semi-solids, and topical liquids.
Differentiator
Problem solved
Functional benefit
Products and services
- Full Service Production
Quantifiable outcome
- Reduced development time and costs through access to over 60 ready-to-market medical device references
- +1 more outcomes
Companies that use The Healthea Group
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
The Healthea Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
The Healthea Group partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- BiokosmescoreItalian B2B contract manufacturing company with over 40 years of experience in research, development, and production of cosmetics and medical devices. Acquired as business unit from Venture Life Group plc. Specializes in full-service approach from product concept to final packaging.
- Rolf Kullgren ABcoreSwedish contract manufacturing company specializing in medical devices and cosmetics, acquired as business unit from Venture Life Group plc. Part of expansion bringing total facilities to seven.
- BMG PharmacoreItalian B2B company specialized in development and out-licensing of innovative patented products for oral health, dermatology, and nutraceutical sectors. First add-on acquisition under Riverside ownership, adding 15 medical devices in oral-care and dermatology therapeutic areas.
- Universities and Research CentersminorCollaborations with universities and research centers for development of new technologies and product performance improvement, including preclinical and clinical efficacy and safety studies on formulations.
- StartupsminorStrategic partnerships with startups for joint development of new technologies and innovation in the healthcare sector.
- Venture Life Group plc (VLG)minorUK-quoted consumer healthcare group from which Biokosmes and Rolf Kullgren business units were acquired. At closing, VLG will enter into long-term manufacturing agreement with BioDue for exclusive manufacturing of numerous products.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
The Healthea Group competitors and assessment
Company assessmentDirect peers
- Recipharm: Recipharm is a Sweden-headquartered CDMO offering contract development and manufacturing services for pharmaceuticals, with multiple European production sites. It is highly comparable to The Healthea Group as a European multi-site CDMO serving pharma and consumer health customers across similar dosage forms.
- Famar Group: Famar is a European CDMO with multiple manufacturing sites offering services across pharmaceuticals, consumer health, and cosmetics. It is comparable to The Healthea Group as a multi-site European contract manufacturer serving similar end markets.
- Aenova Group: Aenova is a German-headquartered European CDMO producing solid, semi-solid, liquid, and sterile dosage forms for pharma and consumer health customers. It competes directly with Healthea in the European full-service CDMO market across similar therapeutic categories.
- ACS Dobfar: ACS Dobfar is an Italian CDMO focused on sterile injectable manufacturing and active pharmaceutical ingredients for the global pharmaceutical industry. It is comparable to Healthea as an Italian-based European CDMO operating in pharmaceutical contract manufacturing.
- NextPharma: NextPharma is a UK-headquartered European CDMO with facilities across Europe offering contract manufacturing for solid, semi-solid, and liquid dosage forms. It is a comparable full-service European CDMO serving pharma and consumer health customers.
- BSP Pharmaceuticals: BSP Pharmaceuticals is an Italian CDMO specializing in sterile injectable and cytotoxic manufacturing for oncology and other therapeutic areas. It is comparable to Healthea as an Italian-headquartered CDMO serving European pharma customers with specialty manufacturing capabilities.
Broad incumbents
- Thermo Fisher Scientific (Patheon CDMO): Thermo Fisher's Patheon CDMO business offers global contract development and manufacturing services for small and large molecule drugs. It is comparable as a major incumbent CDMO with overlapping pharmaceutical manufacturing capabilities and global reach beyond Healthea's European footprint.
- Catalent: Catalent is a global CDMO with broad capabilities across oral, injectable, and biologic dosage forms serving large pharma customers worldwide. It is comparable to The Healthea Group as a CDMO operating in overlapping therapeutic and dosage-form categories, though at significantly larger scale and geographic breadth.
Emerging players
- Adare Pharmaceuticals: Adare Pharmaceuticals is a US-headquartered specialty CDMO with expertise in oral solid dose technologies and patient-friendly formulations. It is comparable to Healthea as a CDMO focused on differentiated oral solid dose delivery technologies serving pharma customers.
Others
- Bormioli Pharma: Bormioli Pharma is an Italian-headquartered supplier of primary packaging containers and packaging solutions for the pharmaceutical industry. It is comparable to Healthea as an Italian-headquartered pharmaceutical packaging partner serving similar European pharma and CDMO customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
The Healthea Group social profiles
Digital presenceThe Healthea Group compliance and trust
Trust signalCompliance1 record
The Healthea Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Healthea Group leadership team
Management profileNumber of profiles
Profiles5 records
The Healthea Group subsidiaries and ownership
Company hierarchySubsidiaries5 records
The Healthea Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Healthea Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Healthea Group
What does The Healthea Group do?
The Healthea Group is a European CDMO providing contract development and manufacturing services for medical devices, cosmetics, food supplements, and foods for special medical purposes. It offers a full-service production model covering R&D, formulation, manufacturing, packaging, regulatory affairs, and logistics, supported by 7 facilities across Italy and Sweden and a portfolio of over 60 ready-to-market medical device references.
Is The Healthea Group a public or private company?
The Healthea Group is a private company. It is classified as private equity controlled and is currently operating.
When was The Healthea Group founded?
The Healthea Group was founded in 2025. It employs 1 to 10 people.
Where is The Healthea Group based?
The Healthea Group is headquartered in Barberino Tavarnelle, Italy, in the Europe region.
How does The Healthea Group make money?
Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are ready-to-Market Products and R&D and Regulatory Services.
Who are The Healthea Group's main competitors?
Direct peers on record are Recipharm, Famar Group, Aenova Group, ACS Dobfar, NextPharma and BSP Pharmaceuticals. Broad incumbents are Thermo Fisher Scientific (Patheon CDMO) and Catalent. Adare Pharmaceuticals is listed as an emerging player. Bormioli Pharma is listed as an others.
Does The Healthea Group have an API?
No public API is recorded for The Healthea Group.
What industry is The Healthea Group in?
The Healthea Group's product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAA, Small-Molecule API & Intermediates CDMO. Its NAICS code is 325412 and its SIC code is 2834.